・It is unclear what the company intends to charge for the vials, the report said. ・Unlike Novo, Eli Lilly and Company already sells its obesity drug Zepbound in both injector pen and vial formats.

It took decades to develop the first treatments to address the root causes of Alzheimer’s disease, and when they first reached patients, they weren’t exactly convenient to take. Patients have to visit ...

Many people living with rheumatoid arthritis (RA) rely on long-term medications to manage joint pain, stiffness, and inflammation. A number of these treatments are given as subcutaneous injections, ...

Hims & Hers Health (NYSE: HIMS) stock crashed 25% through 10:45 a.m. ET Monday morning after an eventful weekend. Where to invest $1,000 right now? Our analyst team just revealed what they believe are ...

Novo Nordisk (NYSE: NVO) is taking investors on another rollercoaster ride. Last week, shares of the Danish pharmaceuticals stock tumbled as much as 27% on news that compounded pharmaceuticals firm ...

Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted Priority Review for the company’s supplemental Biologics License Application (sBLA) ...

Submission is to expand HYMPAVZI indication to the treatment of hemophilia A or B patients 6 years and older with inhibitors, and pediatric patients (ages 6 to 11) without inhibitors If approved, ...

What do tennis star Serena Williams, television personality Oprah Winfrey and actors Kathy Bates and Whoopi Goldberg have in common? They are some of the many celebrities who have spoken publicly ...

Welcome to Camurus' Q4 Report 2025. [Operator Instructions] Now I'll hand the conference over to CEO, Fred Tiberg. Please go ahead. Thank you, Einar, and hello, everyone. Welcome to our fourth quarter ...

Feb 12 (Reuters) - West Pharmaceutical (WST.N), opens new tab forecast annual profit above Wall Street estimates on Thursday, banking on higher demand for diabetes and obesity treatments that use its ...

Novo Nordisk A/S said it’s suing Hims & Hers Health Inc. for making knock-offs of its obesity medicines, even as Hims scrapped plans to sell a copycat version of the Wegovy pill. Hims is breaching the ...